S&P 500   3,139.79 (+0.23%)
DOW   27,882.82 (+0.00%)
QQQ   204.82 (+0.45%)
AAPL   270.34 (+0.69%)
FB   201.84 (+0.48%)
MSFT   151.50 (+0.24%)
GOOGL   1,343.39 (+0.04%)
AMZN   1,746.11 (+0.40%)
CGC   20.45 (+1.79%)
NVDA   216.82 (+1.33%)
MU   49.09 (+3.43%)
BABA   204.12 (+1.83%)
GE   11.03 (+0.18%)
T   38.09 (+0.05%)
AMD   39.39 (-0.13%)
ACB   2.47 (-1.98%)
F   9.13 (+0.66%)
PRI   135.31 (+0.03%)
BAC   33.75 (+0.63%)
DIS   147.52 (+0.97%)
S&P 500   3,139.79 (+0.23%)
DOW   27,882.82 (+0.00%)
QQQ   204.82 (+0.45%)
AAPL   270.34 (+0.69%)
FB   201.84 (+0.48%)
MSFT   151.50 (+0.24%)
GOOGL   1,343.39 (+0.04%)
AMZN   1,746.11 (+0.40%)
CGC   20.45 (+1.79%)
NVDA   216.82 (+1.33%)
MU   49.09 (+3.43%)
BABA   204.12 (+1.83%)
GE   11.03 (+0.18%)
T   38.09 (+0.05%)
AMD   39.39 (-0.13%)
ACB   2.47 (-1.98%)
F   9.13 (+0.66%)
PRI   135.31 (+0.03%)
BAC   33.75 (+0.63%)
DIS   147.52 (+0.97%)
S&P 500   3,139.79 (+0.23%)
DOW   27,882.82 (+0.00%)
QQQ   204.82 (+0.45%)
AAPL   270.34 (+0.69%)
FB   201.84 (+0.48%)
MSFT   151.50 (+0.24%)
GOOGL   1,343.39 (+0.04%)
AMZN   1,746.11 (+0.40%)
CGC   20.45 (+1.79%)
NVDA   216.82 (+1.33%)
MU   49.09 (+3.43%)
BABA   204.12 (+1.83%)
GE   11.03 (+0.18%)
T   38.09 (+0.05%)
AMD   39.39 (-0.13%)
ACB   2.47 (-1.98%)
F   9.13 (+0.66%)
PRI   135.31 (+0.03%)
BAC   33.75 (+0.63%)
DIS   147.52 (+0.97%)
S&P 500   3,139.79 (+0.23%)
DOW   27,882.82 (+0.00%)
QQQ   204.82 (+0.45%)
AAPL   270.34 (+0.69%)
FB   201.84 (+0.48%)
MSFT   151.50 (+0.24%)
GOOGL   1,343.39 (+0.04%)
AMZN   1,746.11 (+0.40%)
CGC   20.45 (+1.79%)
NVDA   216.82 (+1.33%)
MU   49.09 (+3.43%)
BABA   204.12 (+1.83%)
GE   11.03 (+0.18%)
T   38.09 (+0.05%)
AMD   39.39 (-0.13%)
ACB   2.47 (-1.98%)
F   9.13 (+0.66%)
PRI   135.31 (+0.03%)
BAC   33.75 (+0.63%)
DIS   147.52 (+0.97%)
Log in

NYSE:SYK - Stryker Stock Price, Forecast & News

$197.45
-0.68 (-0.34 %)
(As of 12/11/2019 02:27 PM ET)
Today's Range
$197.16
Now: $197.45
$198.91
50-Day Range
$198.20
MA: $205.88
$220.63
52-Week Range
$144.75
Now: $197.45
$223.45
Volume1.06 million shs
Average Volume1.23 million shs
Market Capitalization$73.87 billion
P/E Ratio27.01
Dividend Yield1.04%
Beta0.76
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.60 billion
Cash Flow$9.06 per share
Book Value$31.35 per share

Profitability

Net Income$3.55 billion

Miscellaneous

Employees36,000
Market Cap$73.87 billion
Next Earnings Date2/4/2020 (Estimated)
OptionableOptionable

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


Stryker (NYSE:SYK) Frequently Asked Questions

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Thursday, December 5th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.575 per share on Friday, January 31st. This represents a $2.30 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date of this dividend is Monday, December 30th. This is an increase from Stryker's previous quarterly dividend of $0.52. View Stryker's Dividend History.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its quarterly earnings results on Tuesday, October, 29th. The medical technology company reported $1.91 EPS for the quarter, beating analysts' consensus estimates of $1.90 by $0.01. The medical technology company earned $3.59 billion during the quarter, compared to analyst estimates of $3.58 billion. Stryker had a net margin of 23.55% and a return on equity of 25.33%. The company's revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.69 EPS. View Stryker's Earnings History.

When is Stryker's next earnings date?

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Stryker.

What guidance has Stryker issued on next quarter's earnings?

Stryker issued an update on its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.43 to $2.48 for the period, compared to the Thomson Reuters consensus estimate of $2.45.

What price target have analysts set for SYK?

20 brokers have issued 12 month price targets for Stryker's stock. Their forecasts range from $156.75 to $245.00. On average, they expect Stryker's share price to reach $218.36 in the next year. This suggests a possible upside of 10.6% from the stock's current price. View Analyst Price Targets for Stryker.

What is the consensus analysts' recommendation for Stryker?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

Has Stryker been receiving favorable news coverage?

News coverage about SYK stock has trended neutral recently, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stryker earned a daily sentiment score of 0.5 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Stryker.

Are investors shorting Stryker?

Stryker saw a decrease in short interest during the month of October. As of October 15th, there was short interest totalling 3,670,000 shares, a decrease of 23.2% from the September 15th total of 4,780,000 shares. Based on an average trading volume of 1,020,000 shares, the short-interest ratio is presently 3.6 days. Currently, 1.1% of the company's shares are short sold. View Stryker's Current Options Chain.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), Abbott Laboratories (ABT), Walt Disney (DIS), Home Depot (HD), AbbVie (ABBV), Medtronic (MDT), Bank of America (BAC), CVS Health (CVS) and Cisco Systems (CSCO).

Who are Stryker's key executives?

Stryker's management team includes the folowing people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

Who are Stryker's major shareholders?

Stryker's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (3.60%), Massachusetts Financial Services Co. MA (1.47%), California Public Employees Retirement System (0.36%), Sumitomo Mitsui Trust Holdings Inc. (0.35%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.34%) and Parametric Portfolio Associates LLC (0.27%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Keybank National Association OH, Alberta Investment Management Corp, Pictet Asset Management Ltd., Connors Investor Services Inc., Mackay Shields LLC, Man Group plc and Ferguson Wellman Capital Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

Which major investors are buying Stryker stock?

SYK stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, State of New Jersey Common Pension Fund D, First Trust Advisors LP, California Public Employees Retirement System, Columbus Circle Investors, Commerzbank Aktiengesellschaft FI, Stonehage Fleming Financial Services Holdings Ltd and State of Michigan Retirement System. View Insider Buying and Selling for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $197.46.

How big of a company is Stryker?

Stryker has a market capitalization of $73.87 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

What is Stryker's official website?

The official website for Stryker is http://www.strykercorp.com/.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]


MarketBeat Community Rating for Stryker (NYSE SYK)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  736 (Vote Outperform)
Underperform Votes:  715 (Vote Underperform)
Total Votes:  1,451
MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote "Outperform" if you believe SYK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2019 by MarketBeat.com Staff

Featured Article: What is a bull market?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel